Acivicin hydrochloride
(Synonyms: 盐酸阿西维辛; AT-125 hydrochloride; U-42126 hydrochloride) 目录号 : GC60562A glutamine antagonist with anti-
Cas No.:161922-40-3
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Acivicin is a glutamine analog that irreversibly inhibits glutamine-
1.Tso, J.Y., Bower, S.G., and Zalkin, H.Mechanism of inactivation of glutamine amidotransferases by the antitumor drug L-(αS, 5S)-α-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125)J. Biol. Chem.255(14)6734-6738(1980) 2.Lyons, S.D., Sant, M.E., and Christopherson, R.I.Cytotoxic mechanisms of glutamine antagonists in mouse L1210 leukemiaJ. Biol. Chem.265(19)11377-11381(1990) 3.Stole, E., Smith, T.K., Manning, J.M., et al.Interaction of γ-glutamyl transpeptidase with acivicinJ. Biol. Chem.269(34)21435-21439(1994) 4.Smith, T.K., Ikeda, Y., Fujii, J., et al.Different sites of acivicin binding and inactivation of γ-glutamyl transpeptidasesProc. Natl. Acad. Sci. USA922360-2364(1995) 5.Griffith, O.W., and Meister, A.Excretion of cysteine and γ-glutamylcysteine moieties in human and experimental animal γ-glutamyl transpeptidase deficiencyProc. Natl. Acad. Sci. USA77(6)3384-3387(1980) 6.Meck, R.A., Clubb, K.J., Allen, L.M., et al.Inhibition of cell cycle progression of human pancreatic carcinoma cells in vitro by L-(αS,5S)-α-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, acivicin (NSC 163501)Cancer Res.414547-4553(1981) 7.Willoughby, L.F., Schlosser, T., Manning, S.A., et al.An in vivo large-scale chemical screening platform using Drosophila for anti-cancer drug discoveryDis. Model. Mech.6(2)521-529(2012)
Cas No. | 161922-40-3 | SDF | |
别名 | 盐酸阿西维辛; AT-125 hydrochloride; U-42126 hydrochloride | ||
Canonical SMILES | [H]Cl.ClC1=NO[C@@]([C@H](N)C(O)=O)([H])C1 | ||
分子式 | C5H8Cl2N2O3 | 分子量 | 215.03 |
溶解度 | DMSO : 100 mg/mL (465.05 mM; Need ultrasonic) | 储存条件 | 4°C, stored under argon |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 4.6505 mL | 23.2526 mL | 46.5051 mL |
5 mM | 0.9301 mL | 4.6505 mL | 9.301 mL |
10 mM | 0.4651 mL | 2.3253 mL | 4.6505 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。